Stojsic V, Zaric B, Simurdic P, Kovacevic T, Bokan D, Djekic Malbasa J, et al. Real World Data Survival Outcomes of First Line Immunotherapy with Pembrolizumab in High Expressers with stage IV Non-Small Cell Lung Cancer. Radiol Oncol [Internet]. 2026 Sep. 2 [cited 2026 Sep. 3];60(3):450-8. Available from: https://radioloncol.com/index.php/ro/article/view/4876